Development of VHH Antibodies against Dengue Virus Type 2 NS1 and Comparison with Monoclonal Antibodies for Use in Immunological Diagnosis-Reference-Cited by-同舟云学术

Development of VHH Antibodies against Dengue Virus Type 2 NS1 and Comparison with Monoclonal Antibodies for Use in Immunological Diagnosis

Published:2014-04-21 Issue:4 Volume:9 Page:e95263
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fatima Aneela,Wang Haiying,Kang Keren,Xia Liliang,Wang Ying,Ye Wei,Wang Jufang,Wang Xiaoning

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses;JS Mackenzie;Nat Med,2004

2. World Health Organization (2012) Global strategy for dengue prevention and control 2012–2020, WHO report, Geneva.

3. George R, Lum LCS (1997) Clinical spectrum of dengue infection. In: Gubler DJ, Kuno G, eds. Dengue and dengue hemorrhagic fever. CAB International, London, United Kingdom. 89–114.

4. Trends in dengue diagnosis;FR Teles;Rev Med Virol,2005

5. Prospects for a dengue virus vaccine;SS Whitehead;Nat Rev Microbiol,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects;Cell Death & Disease;2024-07-30

2. A review on camelid nanobodies with potential application in veterinary medicine;Veterinary Research Communications;2024-06-13

3. Single-Domain Antibody-Gold Nanoparticle Bioconjugates as Immunosensors for the Detection of Hantaviruses;Molecular Diagnosis & Therapy;2024-05-26

4. Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons;World Journal of Microbiology and Biotechnology;2024-05-21

5. Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects;2024-02-26